NAT1-IN-1 (compound 350) is a potent N-acetyltransferase 1 (NAT1)-targeted inhibitor, with an IC50 of 44 nM. NAT1-IN-1 can be used for the research of hypermetabolic diseases such as amyotrophic lateral sclerosis, cancer cachexia, and sepsis[1].
Molecular Weight:
462.47
Formula:
C24H18N2O6S
Target:
Histone Acetyltransferase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
